📢 Our July social media newsletter is here! 🌞 From groundbreaking partnerships and innovative solutions to inspiring events, we’ve got it all covered. Don’t miss the insightful post by Jurgi Camblong, SOPHiA GENETICS' CEO & Co-founder, about our new partnership in the Basque Country. Enjoy our full LinkedIn newsletter and share it with your network. #DataDrivenMedicine #Innovation #PrecisionMedicine #HealthcareInnovation #Newsletter
SOPHiA GENETICS
Biotechnologieforschung
Democratizing Data-Driven Medicine, Together!
Info
SOPHiA GENETICS is the creator of SOPHiA DDM™, a cloud-based platform capable of analyzing data and generating insights from complex multimodal data sets and different modalities. The SOPHiA DDM™ Platform enables healthcare institutions to get quick, robust insights from their data. We apply our technology to areas such as cancer and inherited disorders, where combining genomic and phenotypic information is vital to support research and drug development efforts. SOPHiA GENETICS' data-sharing methodology also helps researchers and healthcare professionals work together as a community by sharing and leveraging patterns identified via artificial intelligence and machine learning. Our universal platform is designed to improve as we analyze more data over time. The SOPHiA DDM™ Platform is one of the largest technology-agnostic networks of connected healthcare institutions worldwide and is currently used by more than 750 hospital, laboratory, and biopharma institutions globally. ___________ SOPHiA GENETICS Community Guidelines We value the insights and perspectives of all our members. To ensure a constructive environment, we kindly ask everyone to adhere to the following guidelines: - Respectful interactions: treat everyone with respect and courtesy. - Constructive sharing: contribute comments and ideas that are relevant and add value to the conversation. - Stay on-topic: ensure your comments are relevant to the post or discussion. - Avoid inappropriate content: refrain from posting content that is unethical, hateful, offensive, speculations about our stock prices or financial discussions that are not in the scope of the social media platform. - No spam or solicitations: for business inquiries or other topics, kindly use the 'Contact Us' section on our official website. - Moderation rights: we reserve the right to remove comments that do not align with our guidelines, principles and values. By participating in our community, you agree to these guidelines.
- Website
-
http://www.sophiagenetics.com/
Externer Link zu SOPHiA GENETICS
- Branche
- Biotechnologieforschung
- Größe
- 201–500 Beschäftigte
- Hauptsitz
- Rolle
- Art
- Privatunternehmen
- Gegründet
- 2011
- Spezialgebiete
- Bioinformatics, Algorithms, genomics, big data, clinical, artificial intelligence, AI, Machine Learning, Deep Learning, Oncology, Cancer, ctDNA, Liquid Biopsy, Data-Driven Medicine, Precision Medicine und AI in Healthcare
Orte
-
Primär
La Pièce 12
Rolle, 1180, CH
-
185 Dartmouth St
Floor 5
Boston, Massachusetts 02116, US
-
Technopole Izarbel 158 allée Fauste d’Elhuyar
Bidart, 64210, FR
Beschäftigte von SOPHiA GENETICS
Updates
-
Save the Date 📅 Tuesday, August 6, 2024 Get ready to dive into SOPHiA GENETICS' Q2 2024 earnings call. Join us from 8:00am - 9:00am EDT / 2:00pm - 3:00pm CET as we reveal our financial results and discuss our achievements and future plans. 🔗 Tune in live on our Investor Relations site: https://loom.ly/tux1_Jg. A replay will be available for those who want to catch up later. Mark your calendars and stay tuned for more updates! #EarningsCall #DataDrivenMedicine #Press #Media #Investors
-
-
SOPHiA GENETICS hat dies direkt geteilt
I'm excited to share my latest article on leading with passion for innovation at SOPHiA GENETICS, where our customer-centric approach drives everything we do. Thank you to our customers, partners, and dedicated team — together, we're transforming the future of healthcare. Read the full article and share your thoughts! #AIforHealthcare #DataDrivenMedicine
A Day in the Life of a CEO: Driving Customer-Centric Innovation
Jurgi Camblong auf LinkedIn
-
#ESMO2024 Topic Takeover 🎯 Find the right patients, for the right trials with SOPHiA DDM™ Trial Match! Explore real-world data from our vast network to enhance your clinical trials on a global scale. Improve site selection, identify the right biomarkers and patient populations, and shorten enrolment timelines, with on-demand access to the SOPHiA DDM™ Platform. Get more out of ESMO 2024 and book a meeting with us to learn how SOPHiA DDM™ Trial Match can help you accelerate clinical trial enrolment: 🔗 https://loom.ly/3pG0cZA #PrecisionOncology #PrecisionMedicine #AIforHealthcare #ClinicalTrials #Genomics #DataDrivenMedicine
-
-
🇨🇦 Our recent workshop at the The Michener Institute of Education at UHN was a success! We had the pleasure of conducting a hands-on workshop on the combined workflow of SOPHiA DDM™ and Alamut™ Visual Plus. During their final week of the course, soon-to-be-certified lab technologists from Michener attended this engaging session. Featuring a hybrid format, Simon Alfred and Emmanuel Roy led the workshop onsite, and Swati Tomar, Ph.D. remotely. This marks our second year running the workshop, and we hope to continue this tradition. Students shared their positive feedback through a survey, highlighting the value of practical experience in mastering our solutions. ✅ In the survey, an impressive number of students confirmed they would highly recommend SOPHiA GENETICS to other laboratories. We are thrilled to support the next generation of lab technologists and look forward to future collaborations! #DataDrivenMedicine #Genomics #LabTechnologists #MichenerInstitute #HealthcareInnovation
-
-
🇨🇱 We were thrilled to participate in Laboratorio Barnafi Krause's launch event on July 11th in Santiago, Chile, where we had a fascinating discussion about SOPHiA DDM™ for Chronic Lymphocytic Leukemia (CLL). A heartfelt thank you to all who joined and contributed to the dialogue on enhancing genomic capabilities. Together, let's continue to advance towards the future of data-driven medicine! #SOPHiADDM #PrecisionMedicine #DataDrivenMedicine #Oncology
-
-
Join us and The Pathologist tomorrow at 5pm CEST/11am EST for the webinar "Empowering Laboratories with Robust Molecular Analysis: Unlocking MSK-ACCESS®". Take a deep dive into precision oncology with our speakers: • Brian Loomis, PhD, Director of Clinical Next-Generation Sequencing, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center • Florian Klemm, MD, PhD, Technical Product Manager, Genomic Research Expert, SOPHiA GENETICS • Verena Schramm, PhD, VP, Product Management, SOPHiA GENETICS 🚨 Last chance to register: https://ter.li/sdu043 #PrecisionOncology #DataDrivenMedicine #Webinar #LiquidBiopsy
-
SOPHiA GENETICS warmly congratulates the Memorial Sloan Kettering Cancer Center team on this wonderful news. 🤝 We are proud to collaborate with you in the fight against cancer! #DataDrivenMedicine #PrecisionMedicine #FightCancer #BestHospitals
Memorial Sloan Kettering Cancer Center has been ranked the #2 cancer center in the nation, and #1 in the nation for urology care by U.S. News & World Report in its annual Best Hospitals listing. Learn more: https://bit.ly/4bLWGk7
-
-
SOPHiA GENETICS hat dies direkt geteilt
Cancer has touched all of our lives. What if a cancer diagnosis could be managed with more precision for better outcomes? In my latest Fast Company article, I explore how #AI is making this possible. Since 2011, the company I'm leading, SOPHiA GENETICS, has been transforming healthcare by empowering institutions to help patients all over the world. #AIforHealthcare
Advocacy and AI in cancer treatment
fastcompany.com
-
📣 ONE DAY LEFT! Don't miss our live webinar at Frontline Genomics "Enhancing variant interpretation: Obtaining answers from a vast universe of data" 🧬 💡Join us for a webinar where we tackle the challenges of pinpointing pathogenic mutations from large, complex datasets. In this webinar, we will demonstrate how variant interpretation with Alamut™ Visual Plus can improve the accuracy and speed of variant interpretation, using specific case studies, such as detecting compound heterozygous variants in Charcot-Marie-Tooth Disease, and Alu insertions in breast cancer. Rolph Pfundt, Clinical Molecular Geneticist at Radboud University Medical Centre in the Netherlands, will share insights into his variant interpretation workflow, highlighting how Alamut™ Visual Plus enables the identification of complex variants with greater ease and precision. Join this insightful exchange and learn how integrating Alamut™ Visual Plus into your NGS workflow can streamline your genomic analysis, making it quicker and easier. ➡️ Book your spot here: https://loom.ly/vAyOX9g Can't attend live? Register today and access the recorded session on-demand at your own convenience!
-
Ähnliche Seiten
Finanzierung
Letzte Runde
Fremdkapital nach Börsengang15.000.000,00 $
Investor:innen